United States· US:84754-052_50a4bcb2-a7f3-26ad-e063-6394a90ac640
JMSOLUTION MARINE LUMINOUS PEARL SUNSCREEN
A medicinal product containing homosalate; octocrylene; octisalate; avobenzone, registered in United States by GPNY CORP.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HOMOSALATE; OCTOCRYLENE; OCTISALATE; AVOBENZONE
- Manufacturer
- GPNY CORP
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1184754052021 TUBE in 1 BOX (84754-052-02) / 50 mL in 1 TUBE (84754-052-01)
- ndc1184754-052-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/27ba25e2-171e-4a16-91d7-68c1ec597bac GET /v1/drugs/27ba25e2-171e-4a16-91d7-68c1ec597bac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "4.9; 4.85; 2.35; 1.35",
"substance": "HOMOSALATE; OCTOCRYLENE; OCTISALATE; AVOBENZONE",
"productndc": "84754-052",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/50mL; g/50mL; g/50mL; g/50mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about homosalate; octocrylene; octisalate; avobenzone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.